Advertisement

Annals of Nuclear Medicine

, Volume 28, Issue 7, pp 664–668 | Cite as

Contrast between hypervascularized liver lesions and hepatic parenchyma: early dynamic PET versus contrast-enhanced CT

  • Martin FreesmeyerEmail author
  • Thomas Winkens
  • Jan-Henning Schierz
Original Article

Abstract

Objectives

To detect hypervascularized liver lesions, early dynamic (ED) 18F-FDG PET may be an alternative when contrast-enhanced (CE) imaging is infeasible. This retrospective pilot analysis compared contrast between such lesions and liver parenchyma, an important objective image quality variable, in ED PET versus CE CT.

Materials and methods

Twenty-eight hypervascularized liver lesions detected by CE CT [21 (75 %) hepatocellular carcinomas; mean (range) diameter 4.9 ± 3.5 (1–14) cm] in 20 patients were scanned with ED PET. Using regions of interest, maximum and mean lesional and parenchymal signals at baseline, arterial and venous phases were calculated for ED PET and CE CT.

Results

Lesional/parenchymal signal ratio was significantly higher (P < 0.005) with ED PET versus CE CT at the arterial phase and similar between the methods at the venous phase.

Conclusion

In liver imaging, ED PET generates greater lesional–parenchymal contrast during the arterial phase than does CE CT; these observations should be formally, prospectively evaluated.

Keywords

Hypervascular liver lesions Liver Contrast Contrast-enhanced computed tomography Early dynamic 18F-fluorodeoxyglucose positron emission tomography 

Notes

Acknowledgements

We thank Robert Marlowe for editing the manuscript and Dominik Driesch (Biocontrol Jena GmbH, Jena, Germany) for performing statistical analyses. This research was funded from the regular University Hospital Jena budget.

Conflict of interest

None.

References

  1. 1.
    Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, Steinmetz A, Sosna J, Groshar D. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma. Radiology. 2011;260:503–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Chouillard EK, Gumbs AA, Cherqui D. Vascular clamping in liver surgery: physiology, indications and techniques. Ann Surg Innov Res. 2010;4:2.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Conover WJ. Practical nonparametric statistics. New York: Wiley; 1971.Google Scholar
  4. 4.
    Dill T. Contraindications to magnetic resonance imaging: non-invasive imaging. Heart. 2008;94:943–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Field AP, Miles J, Field Z. Discovering statistics using R. Thousand Oaks: Sage; 2012.Google Scholar
  6. 6.
    Freesmeyer M, Lopatta E, Schierz JH, Steenbeck J, Opfermann T, Settmacher U. Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR. Nuklearmedizin. 2012;51:N10–1.PubMedCrossRefGoogle Scholar
  7. 7.
    Hohmann J, Skrok J, Basilico R, Jennett M, Muller A, Wolf KJ, Albrecht T. Characterisation of focal liver lesions with unenhanced and contrast enhanced low MI real time ultrasound: on-site unblinded versus off-site blinded reading. Eur J Radiol. 2012;81:e317–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Marin D, Nelson RC, Rubin GD, Schindera ST, Body CT. Technical advances for improving safety. AJR Am J Roentgenol. 2011;197:33–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Michelson AA. Studies in optics. Chicago: The University of Chicago Press; 1927.Google Scholar
  10. 10.
    Namasivayam S, Salman K, Mittal PK, Martin D, Small WC. Hypervascular hepatic focal lesions: spectrum of imaging features. Curr Probl Diagn Radiol. 2007;36:107–23.PubMedCrossRefGoogle Scholar
  11. 11.
    Rhee CM, Bhan I, Alexander EK, Brunelli SM. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med. 2012;172:153–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Sandstede JJ, Tschammler A, Beer M, Vogelsang C, Wittenberg G, Hahn D. Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT. Eur Radiol. 2001;11:1396–400.PubMedCrossRefGoogle Scholar
  13. 13.
    Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, Marlowe RJ, Freesmeyer M. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions. J Nucl Med. 2013;54:848–54.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Nuclear Medicine 2014

Authors and Affiliations

  • Martin Freesmeyer
    • 1
    Email author
  • Thomas Winkens
    • 1
  • Jan-Henning Schierz
    • 1
  1. 1.Clinic of Nuclear MedicineJena University HospitalJenaGermany

Personalised recommendations